Hisamitsu Pharmaceutical saw the highest growth of 199% in patent filings and 366% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 199% and grants by 366%. GlobalData’s DataBook provides a comprehensive analysis of Hisamitsu Pharmaceutical’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Hisamitsu Pharmaceutical has been focused on protecting inventions in European Patent Office(EPO) with nine publications in Q1 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 25% filings and 14% grants. The European Patent Office(EPO), United States(US), Taiwan(TW), and Canada(CA) patent Office are among the top ten patent offices where Hisamitsu Pharmaceutical is filings its patents. Among the top granted patent authorities, Hisamitsu Pharmaceutical has 33% of its grants in Taiwan(TW), 14% in European Patent Office(EPO) and 14% in United States(US).
B-FLEXION Capital Holdings (Jersey) could be the strongest competitor for Hisamitsu Pharmaceutical
Patents related to climate change and circular economy lead Hisamitsu Pharmaceutical's portfolio
Hisamitsu Pharmaceutical has the highest number of patents in climate change followed by, circular economy and circular plastic economy. For climate change no patents were filed and 20% of patents were granted in Q1 2024.
Drug delivery devices related patents lead Hisamitsu Pharmaceutical portfolio followed by packaging, and low back pain
Hisamitsu Pharmaceutical has highest number of patents in drug delivery devices followed by packaging, low back pain, cancer pain, and petrochemicals. For drug delivery devices, nearly 33% of patents were filed and 18% of patents were granted in Q1 2024.
For comprehensive analysis of Hisamitsu Pharmaceutical's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
